On the morning of April 13, the FDA and CDC recommended pausing the use of Johnson & Johnson (Janssen) COVID-19 vaccine while a potential side effect is under review by the Advisory Committee on Immunization Practices on Wednesday.
On the morning of April 13, the FDA and CDC recommended pausing the use of Johnson & Johnson (Janssen) COVID-19 vaccine while a potential side effect is under review by the Advisory Committee on Immunization Practices on Wednesday. At this time, Broomfield Public Health is pausing the use of Johnson & Johnson (Janssen) until more information is made available by the FDA, CDC and the Colorado Department of Public Health and Environment. What you need to know:
- Six vaccine recipients out of 6.8 million have reported a rare type of blood clot after receiving the Johnson & Johnson (Janssen) vaccine. The FDA and CDC are investigating.
- If you made an appointment with Broomfield Public Health for today’s 1STBANK Clinic, you will now be offered Pfizer at your appointment. Your appointment time will remain the same. Visit Broomfield.org/COVIDVaccine for the Pfizer vaccine Fact Sheet.
- If you made an appointment with a different provider for a Johnson & Johnson (Janssen) vaccine, please contact that provider for more information.
As additional information is available, it will be updated on Broomfield.org/COVIDVaccine. To view the FDA and CDC statement, please visit https://bit.ly/3g6qkXT.